John E. Palardy

1.8k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

John E. Palardy is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, John E. Palardy has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 9 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in John E. Palardy's work include Immune Response and Inflammation (21 papers), Neutropenia and Cancer Infections (6 papers) and Sepsis Diagnosis and Treatment (5 papers). John E. Palardy is often cited by papers focused on Immune Response and Inflammation (21 papers), Neutropenia and Cancer Infections (6 papers) and Sepsis Diagnosis and Treatment (5 papers). John E. Palardy collaborates with scholars based in United States, Canada and Belgium. John E. Palardy's co-authors include Steven M. Opal, Nicolas A. Parejo, John P. Pribble, Patrick J. Scannon, Mark White, Jon H. Lemke, Jean‐Louis Vincent, Stephen F. Carroll, James C. Keith and Yow‐Pin Lim and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John E. Palardy

30 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock

1999 505 citations Steven M. Opal, Patrick J. Scannon et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John E. Palardy United States	20	617	475	342	175	167	30	1.4k
Nicolas A. Parejo United States	16	477 0.8×	392 0.8×	218 0.6×	64 0.4×	103 0.6×	22	1.0k
J. Gérain Belgium	14	412 0.7×	354 0.7×	203 0.6×	60 0.3×	195 1.2×	31	1.1k
Judith Branger Netherlands	20	640 1.0×	614 1.3×	347 1.0×	53 0.3×	180 1.1×	29	1.6k
Silvia M. Uriarte United States	28	880 1.4×	441 0.9×	628 1.8×	42 0.2×	195 1.2×	76	2.2k
Milena Karina Coló Brunialti Brazil	24	899 1.5×	718 1.5×	530 1.5×	43 0.2×	185 1.1×	74	2.0k
Catherine Valentine United States	9	679 1.1×	431 0.9×	372 1.1×	34 0.2×	125 0.7×	9	1.4k
Jared T. Muenzer United States	20	896 1.5×	877 1.8×	342 1.0×	44 0.3×	188 1.1×	35	1.9k
Christopher G. Davis United States	19	899 1.5×	682 1.4×	468 1.4×	38 0.2×	160 1.0×	28	1.7k
Patrick J. Scannon United States	13	645 1.0×	503 1.1×	347 1.0×	32 0.2×	210 1.3×	24	1.5k
Naeem K. Patil United States	23	876 1.4×	530 1.1×	398 1.2×	35 0.2×	135 0.8×	33	1.6k

Countries citing papers authored by John E. Palardy

Since Specialization

Citations

This map shows the geographic impact of John E. Palardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Palardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Palardy more than expected).

Fields of papers citing papers by John E. Palardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Palardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Palardy. The network helps show where John E. Palardy may publish in the future.

Co-authorship network of co-authors of John E. Palardy

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Palardy. A scholar is included among the top collaborators of John E. Palardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Palardy. John E. Palardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Opal, Steven M., James L. Ellis, Vipin Suri, et al.. (2015). PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS. Shock. 45(4). 411–418. 44 indexed citations

Ramachandran, Girish, Raymond Kaempfer, Chun‐Shiang Chung, et al.. (2014). CD28 Homodimer Interface Mimetic Peptide Acts as a Preventive and Therapeutic Agent in Models of Severe Bacterial Sepsis and Gram-Negative Bacterial Peritonitis. The Journal of Infectious Diseases. 211(6). 995–1003. 30 indexed citations

Christaki, Eirini, Steven M. Opal, James C. Keith, et al.. (2011). A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal Pneumonia. Shock. 35(5). 492–498. 44 indexed citations

Christaki, Eirini, Steven M. Opal, James C. Keith, et al.. (2010). Estrogen Receptor β Agonism Increases Survival in Experimentally Induced Sepsis and Ameliorates the Genomic Sepsis Signature: A Pharmacogenomic Study. The Journal of Infectious Diseases. 201(8). 1250–1257. 36 indexed citations

Gregory, Stephen H., Wilbur H. Chen, Stephanie Mott, et al.. (2010). Detoxified Endotoxin Vaccine (J5dLPS/OMP) Protects Mice Against Lethal Respiratory Challenge with Francisella tularensis SchuS4. Vaccine. 28(16). 2908–2915. 10 indexed citations

Opal, Steven M., Yow‐Pin Lim, Patricia Cristofaro, et al.. (2010). Inter-α Inhibitor Proteins. Shock. 35(1). 42–44. 28 indexed citations

Lutterloh, Emily, Steven M. Opal, Debra D. Pittman, et al.. (2007). Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Critical Care. 11(6). R122–R122. 135 indexed citations

Opal, Steven M., Yow‐Pin Lim, Lyle L. Moldawer, et al.. (2007). Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: A potential clinical marker and mediator of severe sepsis*. Critical Care Medicine. 35(2). 387–392. 39 indexed citations

Opal, Steven M., John E. Palardy, Patricia Cristofaro, et al.. (2005). THE ACTIVITY OF PATHWAY-SELECTIVE ESTROGEN RECEPTOR LIGANDS IN EXPERIMENTAL SEPTIC SHOCK. Shock. 24(6). 535–540. 7 indexed citations

10.

Opal, Steven M., John E. Palardy, Wilbur H. Chen, et al.. (2005). Active Immunization with a Detoxified Endotoxin Vaccine Protects against Lethal Polymicrobial Sepsis: Its Use with CpG Adjuvant and Potential Mechanisms. The Journal of Infectious Diseases. 192(12). 2074–2080. 26 indexed citations

11.

Artenstein, Andrew W., Steven M. Opal, Patricia Cristofaro, et al.. (2004). Chloroquine Enhances Survival inBacillusanthracisIntoxication. The Journal of Infectious Diseases. 190(9). 1655–1660. 25 indexed citations

12.

Cross, Alan S., Steven M. Opal, John E. Palardy, et al.. (2003). Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects. Vaccine. 21(31). 4576–4587. 27 indexed citations

13.

Opal, Steven M., et al.. (2003). Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Critical Care Medicine. 31(3). 929–932. 24 indexed citations

14.

Lim, Yow‐Pin, et al.. (2003). Correlation between Mortality and the Levels of Inter‐Alpha Inhibitors in the Plasma of Patients with Severe Sepsis. The Journal of Infectious Diseases. 188(6). 919–926. 95 indexed citations

15.

Opal, Steven M., et al.. (2002). Orally Administered Recombinant Human Interleukin‐11 Is Protective in Experimental Neutropenic Sepsis. The Journal of Infectious Diseases. 187(1). 70–76. 21 indexed citations

16.

Opal, Steven M., et al.. (2001). EVALUATION OF THE SAFETY OF RECOMBINANT P-SELECTIN GLYCOPROTEIN LIGAND-IMMUNOGLOBULIN G FUSION PROTEIN IN EXPERIMENTAL MODELS OF LOCALIZED AND SYSTEMIC INFECTION. Shock. 15(4). 285–290. 13 indexed citations

17.

Opal, Steven M., et al.. (2001). Active Immunization with a DetoxifiedEscherichia coliJ5 Lipopolysaccharide Group B Meningococcal Outer Membrane Protein Complex Vaccine Protects Animals from Experimental Sepsis. The Journal of Infectious Diseases. 183(7). 1079–1086. 38 indexed citations

18.

Opal, Steven M., James C. Keith, John E. Palardy, & Nicolas A. Parejo. (2000). Recombinant Human Interleukin‐11 Has Anti‐inflammatory Actions Yet Does Not Exacerbate SystemicListeriaInfection. The Journal of Infectious Diseases. 181(2). 754–756. 12 indexed citations

19.

Opal, Steven M., Patrick J. Scannon, Jean‐Louis Vincent, et al.. (1999). Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock. The Journal of Infectious Diseases. 180(5). 1584–1589. 505 indexed citations breakdown →

20.

Fisher, Charles J., M N Marra, John E. Palardy, et al.. (1994). Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge. Critical Care Medicine. 22(4). 553–558. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact